Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Misonix Inc. (MSON)

19.67   0.64 (3.36%) 11-19 12:20
Open: 18.75 Pre. Close: 19.03
High: 20.28 Low: 18.75
Volume: 67,512 Market Cap: 302M
Misonix Inc designs, manufactures, markets and develops minimally invasive ultrasonic surgical device products. Its products include the BoneScalpel surgical system, the SonaStar Surgical Aspirator and the SonicOne Wound Cleansing and Debridement System.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.215 - 19.342 19.342 - 19.457
Low: 16.585 - 16.732 16.732 - 16.865
Close: 18.779 - 19.035 19.035 - 19.267

Technical analysis

as of: 2019-11-19 11:59:52 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 23.96     One year: 27.98
Support: Support1: 18.05    Support2: 16.53
Resistance: Resistance1: 20.51    Resistance2: 23.96
Pivot: 17.89
Moving Average: MA(5): 18.18     MA(20): 17.91
MA(100): 20.28     MA(250): 19.63
MACD: MACD(12,26): 0.12     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 51.01     %D(3): 34.28
RSI: RSI(14): 60.25
52-week: High: 27.54  Low: 14.13  Change(%): 19.6
Average Vol(K): 3-Month: 4467  10-Days: 6866

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MSON has closed below upper band by 2.3%. Bollinger Bands are 5.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Coherus Biosciences Inc (NASDAQ: CHRS )(announced that it has produced over 400,000 Udenyca pre-filled syringes to date) Fate Therapeutics Inc (NASDAQ: FATE ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Misonix, Inc. (NASDAQ: MSON ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Morphic Holding Inc (NASDAQ: MORF )(IPOed June 27) Odonate Therapeutics Inc (NASDAQ: ODT ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) ResMed Inc. (NYSE: RMD ) Tricida Inc (NASDAQ: TCDA ) Vapotherm Inc (NYSE: VAPO ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 1) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Artelo Biosciences Inc (NASDAQ: ARTL ) CELLECT …

The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 5) Array Biopharma Inc (NASDAQ: ARRY ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) EXACT Sciences Corporation (NASDAQ: EXAS ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Uniqure NV (NASDAQ: QURE ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on June 5) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Caladrius Biosciences Inc (NASDAQ: CLBS ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) ChemoCentryx Inc (NASDAQ: CCXI )(moved in sympathy with its rival, which has a competing drug) Collegium Pharmaceutical Inc (NASDAQ: COLL ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Harvard Bioscience, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 15.36
Shares Float (M) 10.03
% Held by Insiders 19.53
% Held by Institutions 23.84
Shares Short (K) 381
Shares Short P. Month (K)

Stock Financials

EPS -0.320
Book Value (p.s.) 8.550
PEG Ratio -1.56
Profit Margin -7.33
Operating Margin -12.96
Return on Assets (ttm) -3.2
Return on Equity (ttm) -3.8
Qtrly Rev. Growth 19.1
Gross Profit (p.s.) 1.776
Sales Per Share
EBITDA (p.s.) -0.229
Qtrly Earnings Growth
Operating Cash Flow (M) -7.30
Levered Free Cash Flow (M) -3.14

Stock Valuations

P/E -61.69
P/E Growth Ratio 0.04
P/BV 2.31
P/S 4.60
P/CF -41.54

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.